Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Catalysts for change: the cellular neurobiology of psychedelics
Matthew I. Banks, Zarmeen Zahid, N. Jones, et al.
Molecular Biology of the Cell (2021) Vol. 32, Iss. 12, pp. 1135-1144
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 183
Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity
David E. Olson
Biochemistry (2022) Vol. 61, Iss. 3, pp. 127-136
Open Access | Times Cited: 79
Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions
Mauro Cavarra, Alessandra Falzone, Johannes G. Ramaekers, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 71
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Wolves Among Sheep: Sexual Violations in Psychedelic-Assisted Therapy
Tahlia R. Harrison, Sonya C. Faber, Manzar Zare, et al.
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 40-55
Closed Access | Times Cited: 6
Classic Psychedelic Drugs: Update on Biological Mechanisms
Franz X. Vollenweider, John Smallridge
Pharmacopsychiatry (2022) Vol. 55, Iss. 03, pp. 121-138
Open Access | Times Cited: 68
Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development
R. C. Van Court, Matthew S. Wiseman, Kuno Meyer, et al.
Fungal Biology (2022) Vol. 126, Iss. 4, pp. 308-319
Open Access | Times Cited: 60
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
Devon Stoliker, Gary F. Egan, Karl Friston, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 876-917
Open Access | Times Cited: 56
Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin
Devon Stoliker, Leonardo Novelli, Franz X. Vollenweider, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 1, pp. 57-66
Open Access | Times Cited: 12
Psychedelic‐inspired approaches for treating neurodegenerative disorders
Hannah N. Saeger, David E. Olson
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 109-127
Open Access | Times Cited: 33
The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex
Lynette A. Desouza, Madhurima Benekareddy, Sashaina E. Fanibunda, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 33
The potential of psychedelics for the treatment of Alzheimer's disease and related dementias
Michael Winkelman, Attila Szabó, Ede Frecska
European Neuropsychopharmacology (2023) Vol. 76, pp. 3-16
Open Access | Times Cited: 14
Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes
Jacopo Sapienza, Marta Bosia, Marco Spangaro, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 1, pp. 59-67
Closed Access | Times Cited: 19
A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
Blerida Banushi, Vince Polito
Biology (2023) Vol. 12, Iss. 11, pp. 1380-1380
Open Access | Times Cited: 12
A qualitative analysis of the psychedelic mushroom come-up and come-down
Ari Brouwer, Joshua K. Brown, Earth Erowid, et al.
npj Mental Health Research (2025) Vol. 4, Iss. 1
Open Access
Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis
Simon Reiche, Tim Hirschfeld, Anna Gröticke, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111353-111353
Open Access
Not in the drug, not in the brain: Causality in psychedelic experiences from an enactive perspective
Daniel Meling, Milan Scheidegger
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 10
How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework
Manon van den Berg, Igor Magaraggia, Rudy Schreiber, et al.
Psychopharmacology (2022) Vol. 239, Iss. 6, pp. 1853-1879
Open Access | Times Cited: 11
Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions
Nadav Liam Modlin, Michael Creed, Maria Sarang, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 109-135
Open Access | Times Cited: 1
Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis
Noah D. Gold, Austin Mallard, Jacob C. Hermann, et al.
Journal of Palliative Medicine (2023) Vol. 26, Iss. 10, pp. 1408-1418
Closed Access | Times Cited: 2
Divergent Effects of Ketamine and the Serotoninergic Psychedelic 2,5-Dimethoxy-4-Iodoamphetamine on Hippocampal Plasticity and Metaplasticity
Zarmeen Zahid, Ziyad W. Sultan, Bryan M. Krause, et al.
Psychedelic Medicine (2024) Vol. 2, Iss. 3, pp. 166-177
Closed Access
"Vine of the Soul": The Potential of Ayahuasca for Reducing Depression, Anxiety, and Stress among Ceremony Participants and the Role of Rumination
Banan Ramarushton
(2024)
Open Access
Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents
Lucas L. Dwiel, Angela M. Henricks, Elise M. Bragg, et al.
Psychedelic Medicine (2023) Vol. 1, Iss. 1, pp. 43-53
Open Access | Times Cited: 1
A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness
Jaden Brandt
Drug Science Policy and Law (2023) Vol. 9
Open Access | Times Cited: 1
Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents
Lucas L. Dwiel, Angela M. Henricks, Elise M. Bragg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top